Vanguard Group Inc Celcuity Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Celcuity Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,565,589 shares of CELC stock, worth $23.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,565,589
Previous 828,597
88.94%
Holding current value
$23.5 Million
Previous $17.9 Million
43.29%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CELC
# of Institutions
93Shares Held
30.1MCall Options Held
4.8KPut Options Held
126K-
Bvf Inc San Francisco, CA3.47MShares$51.9 Million1.74% of portfolio
-
Morgan Stanley New York, NY2.84MShares$42.5 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$35.4 Million1.12% of portfolio
-
Baker Bros. Advisors LP New York, NY1.87MShares$28.1 Million0.41% of portfolio
-
Eventide Asset Management, LLC Boston, MA1.54MShares$23 Million0.44% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $224M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...